Burkert Fluid Control
Systems India Private Limited, a leading manufacturer of measurement and
control systems for liquids and gases, inaugurated its new manufacturing
facility in Pune, Maharashtra, with a grand ceremony. This state-of-the-art
facility is a significant addition to Burkert's global value chain, aimed at
meeting the growing demand in the region by producing components and system
solutions.
Located in Talegaon MIDC,
Phase 2, the new facility spans 50,000 square feet and is equipped with
advanced machining centers, assembly lines, and testing centers designed for
optimum productivity. It has the capacity to produce over 30,000 valves and 500
systems annually. This new unit brings production closer to Burkert's
customers, boosting local employment and enhancing service delivery. Initially,
the Talegaon facility will focus on manufacturing Mass Flow Controllers, Angle
Seat Valves, Diaphragm Valves, and System Solutions, with plans to expand
production in phases to meet the diverse needs of Indian industries.
Speaking at the launch, Mr. Georg Stawowy, CEO of Bürkert Fluid
Control Systems, said, “The opening of our new manufacturing facility in
India is a testament to our commitment to the Indian market and the
government's 'Make in India' vision. By manufacturing locally, we can better
serve our customers with customized products and systems that meet their
specific needs. Our goal is to make Burkert an integral part of India's
industrial landscape by combining our global expertise with local production
capabilities.”
Mr.
Sadiq Khan, Managing Director of Bürkert Fluid Control Systems India Pvt Ltd,
added, “This facility marks a groundbreaking achievement for Burkert and
becomes the third manufacturing unit to produce the world's best control and
monitoring equipment outside of Europe. This manufacturing unit is a critical
facility to complete the Burkert value chain across the globe.”
The Talegaon unit is
expected to employ up to 32 people by the end of this year, with the potential
to grow to 100 employees next year. Burkert's technology transfer to India has
already been completed for several unique systems, including panels for Zone 1
ATEX classification. This local production will play a pivotal role in
Burkert's long-term profitability goals, with the company expecting the
facility to be profitable by 2028.
Burkert's global turnover
stands at approximately 710 million EUR, with over 3,700 employees worldwide
and a strong investment in R&D, accounting for 6.9% of its total revenue.
In India, Burkert serves notable clients such as Zydus, Alembic, Sun Pharma,
Biocon, Bharat Biotech, and Serum Institute, reinforcing its position as a key
player in the country's industrial sector.
